We also investigated an external patient cohort consisting of 28 normal prostate samples, 98 primary tumours, and 13 bone metastases (16) to investigate the levels of GFRAL, the receptor for GDF-15, in prostate tissues. This evidence concerns the gene GDF15 and neoplasm.